Literature DB >> 20667123

Management of hereditary angioedema: 2010 Canadian approach.

Tom Bowen1, John Brosz, Kristylea Brosz, Jacques Hebert, Bruce Ritchie.   

Abstract

C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada.

Entities:  

Year:  2010        PMID： 20667123      PMCID： PMC2921103          DOI： 10.1186/1710-1492-6-20

Source DB:  PubMed          Journal:  Allergy Asthma Clin Immunol        ISSN： 1710-1484            Impact factor:   3.406


  12 in total

1.  Angioedema without urticaria: a large clinical survey.

Authors:  Lorenza C Zingale; Laura Beltrami; Andrea Zanichelli; Lorena Maggioni; Emanuela Pappalardo; Benedetta Cicardi; Marco Cicardi
Journal:  CMAJ       Date:  2006-10-24       Impact factor: 8.262

2.  Delivery of care to hemophilic children: home care versus hospitalization.

Authors:  H Strawczynski; A Stachewitsch; G Morgenstern; M E Shaw
Journal:  Pediatrics       Date:  1973-06       Impact factor: 7.124

3.  Acquired angioedema.

Authors:  Marco Cicardi; Andrea Zanichelli
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

4.  HAE international home therapy consensus document.

Authors:  Hilary J Longhurst; Henriette Farkas; Timothy Craig; Emel Aygören-Pürsün; Claire Bethune; Janne Bjorkander; Konrad Bork; Laurence Bouillet; Henrik Boysen; Anette Bygum; Teresa Caballero; Marco Cicardi; John Dempster; Mark Gompels; Jimmy Gooi; Sofia Grigoriadou; Ursula Huffer; Wolfhart Kreuz; Marcel M Levi; Janet Long; Inmaculada Martinez-Saguer; Michel Raguet; Avner Reshef; Tom Bowen; Bruce Zuraw
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

5.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

Authors:  Tom Bowen; Marco Cicardi; Henriette Farkas; Konrad Bork; Hilary J Longhurst; Bruce Zuraw; Emel Aygoeren-Pürsün; Timothy Craig; Karen Binkley; Jacques Hebert; Bruce Ritchie; Laurence Bouillet; Stephen Betschel; Della Cogar; John Dean; Ramachand Devaraj; Azza Hamed; Palinder Kamra; Paul K Keith; Gina Lacuesta; Eric Leith; Harriet Lyons; Sean Mace; Barbara Mako; Doris Neurath; Man-Chiu Poon; Georges-Etienne Rivard; Robert Schellenberg; Dereth Rowan; Anne Rowe; Donald Stark; Smeeksha Sur; Ellie Tsai; Richard Warrington; Susan Waserman; Rohan Ameratunga; Jonathan Bernstein; Janne Björkander; Kristylea Brosz; John Brosz; Anette Bygum; Teresa Caballero; Mike Frank; George Fust; George Harmat; Amin Kanani; Wolfhart Kreuz; Marcel Levi; Henry Li; Inmaculada Martinez-Saguer; Dumitru Moldovan; Istvan Nagy; Erik W Nielsen; Patrik Nordenfelt; Avner Reshef; Eva Rusicke; Sarah Smith-Foltz; Peter Späth; Lilian Varga; Zhi Yu Xiang
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

Review 6.  Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Authors:  Tom Bowen; Marco Cicardi; Henriette Farkas; Konrad Bork; Wolfhart Kreuz; Lorenza Zingale; Lilian Varga; Inmaculada Martinez-Saguer; Emel Aygören-Pürsün; Karen Binkley; Bruce Zuraw; Alvin Davis; Jacques Hebert; Bruce Ritchie; Jeanne Burnham; Anthony Castaldo; Alejandra Menendez; Istvan Nagy; George Harmat; Christoph Bucher; Gina Lacuesta; Andrew Issekutz; Richard Warrington; William Yang; John Dean; Amin Kanani; Donald Stark; Christine McCusker; Eric Wagner; Georges-Etienne Rivard; Eric Leith; Ellie Tsai; Michael MacSween; John Lyanga; Bazir Serushago; Art Leznoff; Susan Waserman; Jean de Serres
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

7.  Management of hereditary angioedema: a Canadian approach.

Authors:  Tom Bowen; Jacques Hebert; Bruce Ritchie; Jeanne Burnham; Mike MacSween; Richard Warrington; William Yang; Andrew Issekutz; Nick Karitsiotis; Nancy McCombie; Tony Giulivi
Journal:  Transfus Apher Sci       Date:  2003-12       Impact factor: 1.764

8.  How do we treat patients with hereditary angioedema.

Authors:  Marco Cicardi; Lorenza Zingale
Journal:  Transfus Apher Sci       Date:  2003-12       Impact factor: 1.764

Review 9.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Authors:  Tom Bowen; Marco Cicardi; Konrad Bork; Bruce Zuraw; Mike Frank; Bruce Ritchie; Henriette Farkas; Lilian Varga; Lorenza C Zingale; Karen Binkley; Eric Wagner; Peggy Adomaitis; Kristylea Brosz; Jeanne Burnham; Richard Warrington; Chrystyna Kalicinsky; Sean Mace; Christine McCusker; Robert Schellenberg; Lucia Celeste; Jacques Hebert; Karen Valentine; Man-Chiu Poon; Bazir Serushago; Doris Neurath; William Yang; Gina Lacuesta; Andrew Issekutz; Azza Hamed; Palinder Kamra; John Dean; Amin Kanani; Donald Stark; Georges-Etienne Rivard; Eric Leith; Ellie Tsai; Susan Waserman; Paul K Keith; David Page; Silvia Marchesin; Hilary J Longhurst; Wolfhart Kreuz; Eva Rusicke; Inmaculada Martinez-Saguer; Emel Aygören-Pürsün; George Harmat; George Füst; Henry Li; Laurence Bouillet; Teresa Caballero; Dumitru Moldovan; Peter J Späth; Sara Smith-Foltz; Istvan Nagy; Erik W Nielsen; Christoph Bucher; Patrik Nordenfelt; Zhi Yu Xiang
Journal:  Ann Allergy Asthma Immunol       Date:  2008-01       Impact factor: 6.347

10.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406
View more
  10 in total

1.  Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods.

Authors:  Judit Czúcz; Gyula Schaffer; Dorottya Csuka; Szilvia Walentin; Jan Kunde; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

Review 2.  New therapeutics in C1INH deficiency: a review of recent studies and advances.

Authors:  Neil Parikh; Marc A Riedl
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

3.  Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department.

Authors:  Andrew Volans; Robert Ferguson
Journal:  BMJ Case Rep       Date:  2013-01-31

4.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

Authors:  Tom Bowen; Marco Cicardi; Henriette Farkas; Konrad Bork; Hilary J Longhurst; Bruce Zuraw; Emel Aygoeren-Pürsün; Timothy Craig; Karen Binkley; Jacques Hebert; Bruce Ritchie; Laurence Bouillet; Stephen Betschel; Della Cogar; John Dean; Ramachand Devaraj; Azza Hamed; Palinder Kamra; Paul K Keith; Gina Lacuesta; Eric Leith; Harriet Lyons; Sean Mace; Barbara Mako; Doris Neurath; Man-Chiu Poon; Georges-Etienne Rivard; Robert Schellenberg; Dereth Rowan; Anne Rowe; Donald Stark; Smeeksha Sur; Ellie Tsai; Richard Warrington; Susan Waserman; Rohan Ameratunga; Jonathan Bernstein; Janne Björkander; Kristylea Brosz; John Brosz; Anette Bygum; Teresa Caballero; Mike Frank; George Fust; George Harmat; Amin Kanani; Wolfhart Kreuz; Marcel Levi; Henry Li; Inmaculada Martinez-Saguer; Dumitru Moldovan; Istvan Nagy; Erik W Nielsen; Patrik Nordenfelt; Avner Reshef; Eva Rusicke; Sarah Smith-Foltz; Peter Späth; Lilian Varga; Zhi Yu Xiang
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

5.  Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients.

Authors:  C Wintenberger; I Boccon-Gibod; D Launay; O Fain; G Kanny; P Y Jeandel; L Martin; A Gompel; L Bouillet
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

7.  The first probable case of hereditary angioedema in Vietnam.

Authors:  Khanh Bui Van; Doan Nguyen Van
Journal:  Allergy Asthma Immunol Res       Date:  2012-02-10       Impact factor: 5.764

Review 8.  Diagnosis and screening of patients with hereditary angioedema in primary care.

Authors:  Maria Paula Henao; Jennifer L Kraschnewski; Theodore Kelbel; Timothy J Craig
Journal:  Ther Clin Risk Manag       Date:  2016-05-02       Impact factor: 2.423

9.  WAO Guideline for the Management of Hereditary Angioedema.

Authors:  Timothy Craig; Emel Aygören-Pürsün; Konrad Bork; Tom Bowen; Henrik Boysen; Henriette Farkas; Anete Grumach; Constance H Katelaris; Richard Lockey; Hilary Longhurst; William Lumry; Markus Magerl; Immaculada Martinez-Saguer; Bruce Ritchie; Alexander Nast; Ruby Pawankar; Bruce Zuraw; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

10.  Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema.

Authors:  Paweł Kawalec; Przemysław Holko; Anna Paszulewicz
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.